Continuous Glucose Monitoring Systems
SKU
MRR-43676CF422F8
Region
Global
Publication Date
February 2024
Delivery
Immediate
2023
USD 5.54 billion
2030
USD 12.55 billion
2024
USD 6.21 billion
CAGR
12.37%

Continuous Glucose Monitoring Systems Market by Component (Integrated Insulin Pumps, Sensors, Transmitters & Receivers), Demographics (Adult Population, Children Population), Patient Type, End User, Distribution Channel - Global Forecast 2024-2030

[186 Pages Report] The Continuous Glucose Monitoring Systems Market size was estimated at USD 5.54 billion in 2023 and expected to reach USD 6.21 billion in 2024, at a CAGR 12.37% to reach USD 12.55 billion by 2030.

Continuous Glucose Monitoring Systems Market
To learn more about this report, request a free PDF copy

Continuous Glucose Monitoring Systems (CGMS) are advanced medical devices designed to provide real-time glucose readings at regular intervals, typically every few minutes, 24/7. These systems comprise a small sensor that transmits the data wirelessly to a display device, which could be a dedicated receiver, a smartphone, or a smartwatch, enabling the user to monitor their glucose levels without the requirement of traditional fingerstick blood tests. The growing preponderance of diabetes across the globe and the rising awareness of the benefits of continuous glucose monitoring over traditional blood glucose monitoring are driving the market growth. However, devices' high prices and lack of uniform reimbursement can limit market penetration. Inaccuracies in glucose readings due to device calibration issues or interference from external factors also pose a challenge. Furthermore, leveraging big data and advanced analytics to improve predictive capabilities, personalization, and clinical outcomes creates potential opportunities for market growth.

Continuous Glucose Monitoring Systems Market - Global Forecast 2024-2030
To learn more about this report, request a free PDF copy
Component: Increasing utilization of transmitters & receivers in CGM systems for real-time glucose monitoring

Integrated insulin pumps are devices that deliver insulin automatically based on the set basal rate and work in conjunction with continuous glucose monitoring (CGM) systems. They adjust the insulin delivery based on real-time glucose readings. This feature greatly contributes to the seamless management of blood glucose levels in diabetes patients, especially useful for those with intensive insulin therapy needs or those with Type 1 diabetes. Sensors are a crucial part of CGM systems, as they are the components that measure levels of glucose in the interstitial fluid beneath the skin. CGM sensors typically require changing every 7 to 14 days, depending on the model. Patients who desire minimal intrusion and longer wear times prefer sensors with extended life spans. The transmitter is the part of the CGM system that sends real-time glucose data from the sensor to a receiver and smart device. The receiver is the device that displays the glucose data. Some patients prioritize a system that allows the use of their own smartphone as a receiver, whereas others prefer a dedicated device if they are not comfortable using smart devices.

Demographics: Ongoing advancements in children CGM systems to make it more effective and less invasive

Continuous Glucose Monitoring (CGM) systems are crucial for the adult population, especially those diagnosed with Type 1 or Type 2 diabetes. Adults require consistent and accurate monitoring of their blood glucose levels to manage their condition effectively and to prevent acute and long-term complications associated with diabetes. CGM systems for children are designed with special considerations for size, sensitivity, and ease of use, owing to the unique physiological and lifestyle requirements of the pediatric population. These devices help parents and caregivers monitor and manage their child's diabetes more effectively, providing peace of mind and improved quality of life.

Patient Type: Rising significance of CGM system in Type 1 diabetes patient for high accuracy, minimal lag time, and predictive alerts for rapid glucose changes

Patients with Type 1 diabetes rely on external insulin because of the autoimmune destruction of the insulin-producing beta cells in the pancreas. Continuous Glucose Monitoring (CGM) systems for this group provide convenience and crucial tools for the management of glucose levels. These patients need real-time data to adjust insulin doses accurately. CGM systems offer significant advantages over traditional blood glucose monitoring, providing detailed insights into glucose trends, which results in better glycemic control and reduction of hypoglycemia risk. Type 2 diabetes patients might not always require insulin but still need to monitor their glucose levels, especially if they are on sulfonylureas and meglitinides, which increase the risk of hypoglycemia. CGM for Type 2 diabetes is geared towards lifestyle management, including diet and exercise, alongside medication. The use of CGM is progressively becoming more common in this group as the technology becomes more affordable and as evidence mounts that it can help improve glycemic control in non-insulin-treated patients.

End User: Growing preference of CGM systems by home patients with remote data sharing capabilities

Diagnostic centers and clinics represent a significant segment for the deployment of Continuous Glucose Monitoring (CGM) systems. These facilities often serve as the initial point of contact for patients experiencing symptoms of diabetes and for those who require ongoing monitoring for their diagnosed condition. Home healthcare represents a rapidly growing segment for CGM systems, as an increasing number of patients with diabetes prefer to manage their condition in the comfort of their own homes. These devices offer convenience and allow for continuous monitoring without the need to visit a healthcare provider frequently. Intensive Care Units (ICUs) are critical settings wherein patients require constant and close monitoring, including for their glucose levels. CGM systems in ICUs must be highly reliable and capable of integrating with other monitoring equipment to ensure a holistic view of a patient's health status.

Regional Insights

The Americas, led by the United States and Canada, show a strong market for CGM systems, aided by higher purchasing power and well-established healthcare systems implementing the latest technologies. The United States & Canada are prominent in CGM technology, with numerous companies researching and developing new systems, evident from a high number of patents filed in this domain. Consumers in the United States have shown an inclination towards maintaining healthy lifestyles, integrating personal health technology with everyday living. There is significant investment and insurance coverage that promotes the use of CGM systems, making them more accessible to the population. European Union countries demonstrate a robust demand for CGM systems, broadly supported by widespread awareness, a push for lifestyle management of diabetes, and favorable insurance reimbursement scenarios. The European Union’s medical device sector is tightly regulated, ensuring high standards of product quality and safety. Countries including Germany, France, and the UK are leaders in the adoption of CGM systems. The Middle East, particularly the Gulf Cooperation Council (GCC) countries, has high per capita healthcare spending and is rapidly adopting advanced technologies in healthcare. Asia Pacific is undergoing a surge in the demand for CGM systems due to the increasing prevalence of diabetes and heightened awareness about the disease. The rising popularity of wearable technology for health monitoring indicates a broad consumer need for convenient and non-intrusive healthcare devices in the APAC region.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Continuous Glucose Monitoring Systems Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Continuous Glucose Monitoring Systems Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments
  • Sibionics obtains CE Mark for GS1 continuous glucose monitoring system

    Sibionics, a Chinese medical technology startup, has received the CE Mark for its pioneering GS1 Continuous Glucose Monitoring (CGM) system, signaling the green light for the system's sale and usage across the European market. This certification confirms the GS1 CGM's compliance with stringent EU standards for quality, safety, and performance, which are essential for consumer trust. [Published On: 2023-11-02]

  • Dexcom targets Americans with new CGM aimed at non-insulin-using diabetics

    Dexcom is set to revolutionize the continuous glucose monitoring (CGM) market by unveiling a new device tailored for Americans living with Type 2 diabetes who do not require insulin therapy. This strategic move addresses a critical gap, highlighted by Dexcom's research, which is that a mere 5% of this demographic currently utilizes CGM technology. [Published On: 2023-06-26]

  • U.S. FDA Clears Abbott's Freestyle Libre 2 and Freestyle Libre 3 Sensors for Integration with Automated Insulin Delivery Systems

    Abbott has announced FDA clearance for its next-generation FreeStyle Libre 2 and FreeStyle Libre 3 iCGM sensors, paving the way for their seamless integration with automated insulin delivery (AID) systems. Expanding their versatility, the improved sensors offer additional convenience and support for diabetes management by pairing them with insulin pumps to adjust insulin delivery automatically based on continuously monitored glucose levels. [Published On: 2023-03-06]

Key Company Profiles

The report delves into recent significant developments in the Continuous Glucose Monitoring Systems Market, highlighting leading vendors and their innovative profiles. These include A. Menarini Diagnostics s.r.l, Abbott Laboratories, AgaMatrix Inc. by I-Sens Inc., Ascensia Diabetes Care Holdings AG, Dexcom, Inc., F. Hoffmann-La Roche Ltd., Insulet Corporation, Johnson & Johnson Services, Inc., Medtronic PLC, Medtrum Technologies Inc., Nemaura Medical Inc., Novo Nordisk A/S, NXP Semiconductors N.V., Senseonics Holdings Inc., Sibionics, STMicroelectronics N.V., Tandem Diabetes Care, Inc., Texas Instruments Incorporated, and Ypsomed Holding AG.

Market Segmentation & Coverage

This research report categorizes the Continuous Glucose Monitoring Systems Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Component
    • Integrated Insulin Pumps
    • Sensors
    • Transmitters & Receivers
  • Demographics
    • Adult Population
    • Children Population
  • Patient Type
    • Type 1 Diabetes
    • Type 2 Diabetes
  • End User
    • Diagnostic Centers & Clinics
    • Home Healthcare
    • ICUs
  • Distribution Channel
    • Institutional Sales
    • Retail Sales

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Continuous Glucose Monitoring Systems Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Continuous Glucose Monitoring Systems Market?
  3. What are the technology trends and regulatory frameworks in the Continuous Glucose Monitoring Systems Market?
  4. What is the market share of the leading vendors in the Continuous Glucose Monitoring Systems Market?
  5. Which modes and strategic moves are suitable for entering the Continuous Glucose Monitoring Systems Market?

Table of Contents
  1. Preface
    1. Objectives of the Study
    2. Market Segmentation & Coverage
    3. Years Considered for the Study
    4. Currency & Pricing
    5. Language
    6. Stakeholders
  2. Research Methodology
    1. Define: Research Objective
    2. Determine: Research Design
    3. Prepare: Research Instrument
    4. Collect: Data Source
    5. Analyze: Data Interpretation
    6. Formulate: Data Verification
    7. Publish: Research Report
    8. Repeat: Report Update
  3. Executive Summary
  4. Market Overview
  5. Market Insights
    1. Market Dynamics
      1. Drivers
        1. Increasing Number of Incidence of Diabetic Patients Globally
        2. Growing Regulatory Approvals for the CGM Systems
        3. Growing Adoption Rate of CGM Systems in Home Healthcare
      2. Restraints
        1. Occurrence of Adverse Effects and Limited Accuracy of CGM Devices
      3. Opportunities
        1. Technological Advancements and Increased Awareness of CGM Systems
        2. Rising Preferences for Non-invasive Methods and Potential Undiagnosed Patient Population
      4. Challenges
        1. Reimbursement and Stringent Regulatory Issues
    2. Market Segmentation Analysis
      1. Component: Increasing utilization of transmitters & receivers in CGM systems for real-time glucose monitoring
      2. Demographics: Ongoing advancements in children CGM systems to make it more effective and less invasive
      3. Patient Type: Rising significance of CGM system in Type 1 diabetes patient for high accuracy, minimal lag time, and predictive alerts for rapid glucose changes
      4. End User: Growing preference of CGM systems by home patients with remote data sharing capabilities
    3. Market Trend Analysis
    4. Cumulative Impact of Russia-Ukraine Conflict
    5. Cumulative Impact of High Inflation
    6. Porter’s Five Forces Analysis
      1. Threat of New Entrants
      2. Threat of Substitutes
      3. Bargaining Power of Customers
      4. Bargaining Power of Suppliers
      5. Industry Rivalry
    7. Value Chain & Critical Path Analysis
    8. Regulatory Framework
    9. Client Customization
  6. Continuous Glucose Monitoring Systems Market, by Component
    1. Introduction
    2. Integrated Insulin Pumps
    3. Sensors
    4. Transmitters & Receivers
  7. Continuous Glucose Monitoring Systems Market, by Demographics
    1. Introduction
    2. Adult Population
    3. Children Population
  8. Continuous Glucose Monitoring Systems Market, by Patient Type
    1. Introduction
    2. Type 1 Diabetes
    3. Type 2 Diabetes
  9. Continuous Glucose Monitoring Systems Market, by End User
    1. Introduction
    2. Diagnostic Centers & Clinics
    3. Home Healthcare
    4. ICUs
  10. Continuous Glucose Monitoring Systems Market, by Distribution Channel
    1. Introduction
    2. Institutional Sales
    3. Retail Sales
  11. Americas Continuous Glucose Monitoring Systems Market
    1. Introduction
    2. Argentina
    3. Brazil
    4. Canada
    5. Mexico
    6. United States
  12. Asia-Pacific Continuous Glucose Monitoring Systems Market
    1. Introduction
    2. Australia
    3. China
    4. India
    5. Indonesia
    6. Japan
    7. Malaysia
    8. Philippines
    9. Singapore
    10. South Korea
    11. Taiwan
    12. Thailand
    13. Vietnam
  13. Europe, Middle East & Africa Continuous Glucose Monitoring Systems Market
    1. Introduction
    2. Denmark
    3. Egypt
    4. Finland
    5. France
    6. Germany
    7. Israel
    8. Italy
    9. Netherlands
    10. Nigeria
    11. Norway
    12. Poland
    13. Qatar
    14. Russia
    15. Saudi Arabia
    16. South Africa
    17. Spain
    18. Sweden
    19. Switzerland
    20. Turkey
    21. United Arab Emirates
    22. United Kingdom
  14. Competitive Landscape
    1. Market Share Analysis, 2023
    2. FPNV Positioning Matrix, 2023
    3. Competitive Scenario Analysis
      1. Sibionics obtains CE Mark for GS1 continuous glucose monitoring system
      2. Dexcom targets Americans with new CGM aimed at non-insulin-using diabetics
      3. U.S. FDA Clears Abbott's Freestyle Libre 2 and Freestyle Libre 3 Sensors for Integration with Automated Insulin Delivery Systems
  15. Competitive Portfolio
    1. Key Company Profiles
    2. Key Product Portfolio
  16. List of Figures [Total: 26]
    1. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET RESEARCH PROCESS
    2. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2023 VS 2030
    3. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
    4. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
    5. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
    6. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET DYNAMICS
    7. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
    8. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
    9. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2023 VS 2030 (%)
    10. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2023 VS 2024 VS 2030 (USD MILLION)
    11. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2023 VS 2030 (%)
    12. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
    13. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
    14. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
    15. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
    16. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
    17. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    18. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    19. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
    20. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
    21. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    22. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    23. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    24. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    25. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SHARE, BY KEY PLAYER, 2023
    26. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2023
  17. List of Tables [Total: 460]
    1. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SEGMENTATION & COVERAGE
    2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
    3. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2018-2023 (USD MILLION)
    4. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2024-2030 (USD MILLION)
    5. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
    6. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
    7. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    8. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    9. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY INTEGRATED INSULIN PUMPS, BY REGION, 2018-2023 (USD MILLION)
    10. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY INTEGRATED INSULIN PUMPS, BY REGION, 2024-2030 (USD MILLION)
    11. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SENSORS, BY REGION, 2018-2023 (USD MILLION)
    12. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SENSORS, BY REGION, 2024-2030 (USD MILLION)
    13. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TRANSMITTERS & RECEIVERS, BY REGION, 2018-2023 (USD MILLION)
    14. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TRANSMITTERS & RECEIVERS, BY REGION, 2024-2030 (USD MILLION)
    15. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
    16. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
    17. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ADULT POPULATION, BY REGION, 2018-2023 (USD MILLION)
    18. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ADULT POPULATION, BY REGION, 2024-2030 (USD MILLION)
    19. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CHILDREN POPULATION, BY REGION, 2018-2023 (USD MILLION)
    20. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CHILDREN POPULATION, BY REGION, 2024-2030 (USD MILLION)
    21. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
    22. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
    23. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2018-2023 (USD MILLION)
    24. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2024-2030 (USD MILLION)
    25. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2018-2023 (USD MILLION)
    26. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2024-2030 (USD MILLION)
    27. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    28. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    29. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DIAGNOSTIC CENTERS & CLINICS, BY REGION, 2018-2023 (USD MILLION)
    30. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DIAGNOSTIC CENTERS & CLINICS, BY REGION, 2024-2030 (USD MILLION)
    31. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2023 (USD MILLION)
    32. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2024-2030 (USD MILLION)
    33. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ICUS, BY REGION, 2018-2023 (USD MILLION)
    34. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ICUS, BY REGION, 2024-2030 (USD MILLION)
    35. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
    36. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
    37. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY INSTITUTIONAL SALES, BY REGION, 2018-2023 (USD MILLION)
    38. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY INSTITUTIONAL SALES, BY REGION, 2024-2030 (USD MILLION)
    39. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY RETAIL SALES, BY REGION, 2018-2023 (USD MILLION)
    40. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY RETAIL SALES, BY REGION, 2024-2030 (USD MILLION)
    41. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    42. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    43. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
    44. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
    45. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
    46. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
    47. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    48. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    49. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
    50. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
    51. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
    52. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
    53. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    54. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    55. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
    56. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
    57. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
    58. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
    59. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    60. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    61. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
    62. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
    63. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    64. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    65. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
    66. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
    67. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
    68. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
    69. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    70. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    71. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
    72. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
    73. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    74. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    75. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
    76. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
    77. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
    78. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
    79. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    80. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    81. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
    82. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
    83. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    84. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    85. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
    86. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
    87. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
    88. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
    89. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    90. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    91. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
    92. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
    93. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    94. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    95. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
    96. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
    97. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
    98. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
    99. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    100. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    101. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
    102. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
    103. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
    104. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
    105. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    106. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    107. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
    108. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
    109. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
    110. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
    111. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    112. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    113. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
    114. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
    115. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
    116. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
    117. AUSTRALIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    118. AUSTRALIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    119. AUSTRALIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
    120. AUSTRALIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
    121. AUSTRALIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
    122. AUSTRALIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
    123. AUSTRALIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    124. AUSTRALIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    125. AUSTRALIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
    126. AUSTRALIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
    127. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    128. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    129. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
    130. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
    131. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
    132. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
    133. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    134. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    135. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
    136. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
    137. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    138. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    139. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
    140. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
    141. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
    142. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
    143. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    144. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    145. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
    146. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
    147. INDONESIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    148. INDONESIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    149. INDONESIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
    150. INDONESIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
    151. INDONESIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
    152. INDONESIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
    153. INDONESIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    154. INDONESIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    155. INDONESIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
    156. INDONESIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
    157. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    158. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    159. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
    160. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
    161. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
    162. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
    163. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    164. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    165. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
    166. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
    167. MALAYSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    168. MALAYSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    169. MALAYSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
    170. MALAYSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
    171. MALAYSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
    172. MALAYSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
    173. MALAYSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    174. MALAYSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    175. MALAYSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
    176. MALAYSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
    177. PHILIPPINES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    178. PHILIPPINES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    179. PHILIPPINES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
    180. PHILIPPINES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
    181. PHILIPPINES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
    182. PHILIPPINES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
    183. PHILIPPINES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    184. PHILIPPINES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    185. PHILIPPINES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
    186. PHILIPPINES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
    187. SINGAPORE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    188. SINGAPORE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    189. SINGAPORE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
    190. SINGAPORE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
    191. SINGAPORE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
    192. SINGAPORE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
    193. SINGAPORE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    194. SINGAPORE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    195. SINGAPORE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
    196. SINGAPORE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
    197. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    198. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    199. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
    200. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
    201. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
    202. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
    203. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    204. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    205. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
    206. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
    207. TAIWAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    208. TAIWAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    209. TAIWAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
    210. TAIWAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
    211. TAIWAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
    212. TAIWAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
    213. TAIWAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    214. TAIWAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    215. TAIWAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
    216. TAIWAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
    217. THAILAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    218. THAILAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    219. THAILAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
    220. THAILAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
    221. THAILAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
    222. THAILAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
    223. THAILAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    224. THAILAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    225. THAILAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
    226. THAILAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
    227. VIETNAM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    228. VIETNAM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    229. VIETNAM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
    230. VIETNAM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
    231. VIETNAM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
    232. VIETNAM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
    233. VIETNAM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    234. VIETNAM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    235. VIETNAM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
    236. VIETNAM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
    237. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    238. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    239. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
    240. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
    241. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
    242. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
    243. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    244. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    245. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
    246. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
    247. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
    248. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
    249. DENMARK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    250. DENMARK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    251. DENMARK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
    252. DENMARK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
    253. DENMARK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
    254. DENMARK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
    255. DENMARK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    256. DENMARK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    257. DENMARK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
    258. DENMARK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
    259. EGYPT CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    260. EGYPT CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    261. EGYPT CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
    262. EGYPT CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
    263. EGYPT CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
    264. EGYPT CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
    265. EGYPT CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    266. EGYPT CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    267. EGYPT CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
    268. EGYPT CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
    269. FINLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    270. FINLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    271. FINLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
    272. FINLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
    273. FINLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
    274. FINLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
    275. FINLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    276. FINLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    277. FINLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
    278. FINLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
    279. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    280. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    281. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
    282. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
    283. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
    284. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
    285. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    286. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    287. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
    288. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
    289. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    290. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    291. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
    292. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
    293. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
    294. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
    295. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    296. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    297. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
    298. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
    299. ISRAEL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    300. ISRAEL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    301. ISRAEL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
    302. ISRAEL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
    303. ISRAEL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
    304. ISRAEL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
    305. ISRAEL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    306. ISRAEL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    307. ISRAEL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
    308. ISRAEL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
    309. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    310. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    311. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
    312. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
    313. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
    314. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
    315. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    316. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    317. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
    318. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
    319. NETHERLANDS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    320. NETHERLANDS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    321. NETHERLANDS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
    322. NETHERLANDS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
    323. NETHERLANDS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
    324. NETHERLANDS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
    325. NETHERLANDS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    326. NETHERLANDS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    327. NETHERLANDS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
    328. NETHERLANDS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
    329. NIGERIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    330. NIGERIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    331. NIGERIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
    332. NIGERIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
    333. NIGERIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
    334. NIGERIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
    335. NIGERIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    336. NIGERIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    337. NIGERIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
    338. NIGERIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
    339. NORWAY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    340. NORWAY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    341. NORWAY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
    342. NORWAY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
    343. NORWAY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
    344. NORWAY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
    345. NORWAY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    346. NORWAY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    347. NORWAY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
    348. NORWAY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
    349. POLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    350. POLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    351. POLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
    352. POLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
    353. POLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
    354. POLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
    355. POLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    356. POLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    357. POLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
    358. POLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
    359. QATAR CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    360. QATAR CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    361. QATAR CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
    362. QATAR CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
    363. QATAR CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
    364. QATAR CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
    365. QATAR CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    366. QATAR CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    367. QATAR CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
    368. QATAR CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
    369. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    370. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    371. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
    372. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
    373. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
    374. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
    375. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    376. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    377. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
    378. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
    379. SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    380. SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    381. SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
    382. SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
    383. SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
    384. SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
    385. SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    386. SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    387. SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
    388. SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
    389. SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    390. SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    391. SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
    392. SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
    393. SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
    394. SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
    395. SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    396. SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    397. SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
    398. SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
    399. SPAIN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    400. SPAIN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    401. SPAIN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
    402. SPAIN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
    403. SPAIN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
    404. SPAIN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
    405. SPAIN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    406. SPAIN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    407. SPAIN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
    408. SPAIN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
    409. SWEDEN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    410. SWEDEN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    411. SWEDEN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
    412. SWEDEN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
    413. SWEDEN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
    414. SWEDEN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
    415. SWEDEN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    416. SWEDEN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    417. SWEDEN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
    418. SWEDEN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
    419. SWITZERLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    420. SWITZERLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    421. SWITZERLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
    422. SWITZERLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
    423. SWITZERLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
    424. SWITZERLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
    425. SWITZERLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    426. SWITZERLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    427. SWITZERLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
    428. SWITZERLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
    429. TURKEY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    430. TURKEY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    431. TURKEY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
    432. TURKEY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
    433. TURKEY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
    434. TURKEY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
    435. TURKEY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    436. TURKEY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    437. TURKEY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
    438. TURKEY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
    439. UNITED ARAB EMIRATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    440. UNITED ARAB EMIRATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    441. UNITED ARAB EMIRATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
    442. UNITED ARAB EMIRATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
    443. UNITED ARAB EMIRATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
    444. UNITED ARAB EMIRATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
    445. UNITED ARAB EMIRATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    446. UNITED ARAB EMIRATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    447. UNITED ARAB EMIRATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
    448. UNITED ARAB EMIRATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
    449. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    450. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    451. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
    452. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
    453. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
    454. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
    455. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
    456. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
    457. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
    458. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
    459. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SHARE, BY KEY PLAYER, 2023
    460. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2023
  18. List of Companies Mentioned [Total: 19]
    1. A. Menarini Diagnostics s.r.l
    2. Abbott Laboratories
    3. AgaMatrix Inc. by I-Sens Inc.
    4. Ascensia Diabetes Care Holdings AG
    5. Dexcom, Inc.
    6. F. Hoffmann-La Roche Ltd.
    7. Insulet Corporation
    8. Johnson & Johnson Services, Inc.
    9. Medtronic PLC
    10. Medtrum Technologies Inc.
    11. Nemaura Medical Inc.
    12. Novo Nordisk A/S
    13. NXP Semiconductors N.V.
    14. Senseonics Holdings Inc.
    15. Sibionics
    16. STMicroelectronics N.V.
    17. Tandem Diabetes Care, Inc.
    18. Texas Instruments Incorporated
    19. Ypsomed Holding AG
Improving Diabetes Management: Continuous Glucose Monitoring Systems
December 29, 2023
BLOG
Improving Diabetes Management: Continuous Glucose Monitoring Systems
Diabetes Mellitus is a chronic health condition with a widespread global impact, affecting millions of individuals. It arises when the body cannot produce an adequate amount of insulin or efficiently utilize the insulin it produces. This results in elevated blood glucose levels, potentially leading to complications such as cardiovascular and cerebrovascular diseases, nerve damage, blindness, and kidney failure. Given the increasing incidence of diabetes worldwide, there has been a significant increase in the need for more effective diabetes management strategies, especially continuous glucose monitoring (CGM) systems.

CGM systems are advanced medical devices that record and display an individual's glucose levels continuously, especially for people with diabetes. These systems can measure glucose levels in real-time or at set intervals throughout the day, and the data is usually transmitted to a receiver or a mobile application, providing users with updates on glucose levels and trends. Unlike traditional blood glucose monitoring systems, CGMs provide more accurate and near-real-time measurements of glucose levels, making them incredibly useful for tracking blood sugar trends, identifying patterns in glucose levels, and making treatment decisions.

There are several CGM systems on the market today, such as standalone CGMs, which come with both a monitor and a transmitter, and integrated CGMs, which connect to insulin pumps. Some CGMs also come in adhesive patches attached to the skin and can transmit data to a smart device.

CGMs have several advantages that make them an essential tool in diabetes management. One significant advantage is that they help people with diabetes detect hypoglycemia or hyperglycemia early. This early warning allows for prompt intervention, reducing the risk of high and low blood sugar complications. Also, CGMs can provide insights into glucose patterns, assisting clinicians and patients in making informed decisions on diet, lifestyle, and medication.

Despite the advantages, CGMs have some disadvantages, including high cost, technical complexity, and discomfort associated with the insertion of the sensor and the need to calibrate the device. However, these limitations are gradually being addressed as technology advances, making CGMs more accessible and comfortable.

Continuous Glucose Monitoring Systems have revolutionized diabetes management, providing insights into glucose levels that were previously unattainable through traditional blood glucose monitoring. With more advanced and user-friendly CGM devices making their way into the market, there is no doubt that they will become a more common feature in diabetes management, potentially reducing the incidence of complications related to high and low blood sugar.

Frequently Asked Questions
  1. How big is the Continuous Glucose Monitoring Systems Market?
    Ans. The Global Continuous Glucose Monitoring Systems Market size was estimated at USD 5.54 billion in 2023 and expected to reach USD 6.21 billion in 2024.
  2. What is the Continuous Glucose Monitoring Systems Market growth?
    Ans. The Global Continuous Glucose Monitoring Systems Market to grow USD 12.55 billion by 2030, at a CAGR of 12.37%
  3. When do I get the report?
    Ans. Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
  4. In what format does this report get delivered to me?
    Ans. We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
  5. How long has 360iResearch been around?
    Ans. We are approaching our 7th anniversary in 2024!
  6. What if I have a question about your reports?
    Ans. Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
  7. Can I share this report with my team?
    Ans. Absolutely yes, with the purchase of additional user licenses.
  8. Can I use your research in my presentation?
    Ans. Absolutely yes, so long as the 360iResearch cited correctly.
DOWNLOAD A FREE PDF
This free PDF includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.